Follow
Philippe Lambin
Philippe Lambin
Professor of Precision Medicine, Maastricht University & Scientist ULB
Verified email at maastrichtuniversity.nl - Homepage
Title
Cited by
Cited by
Year
Radiomics: extracting more information from medical images using advanced feature analysis
P Lambin, E Rios-Velazquez, R Leijenaar, S Carvalho, ...
European journal of cancer 48 (4), 441-446, 2012
55512012
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ...
Nature communications 5 (1), 4006, 2014
51232014
Radiomics: the bridge between medical imaging and personalized medicine
P Lambin, RTH Leijenaar, TM Deist, J Peerlings, EEC De Jong, ...
Nature reviews Clinical oncology 14 (12), 749-762, 2017
45192017
The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping
A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ...
Radiology 295 (2), 328-338, 2020
28732020
Radiomics: the process and the challenges
V Kumar, Y Gu, S Basu, A Berglund, SA Eschrich, MB Schabath, K Forster, ...
Magnetic resonance imaging 30 (9), 1234-1248, 2012
23322012
Imaging biomarker roadmap for cancer studies
JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
11192017
Machine learning methods for quantitative radiomic biomarkers
C Parmar, P Grossmann, J Bussink, P Lambin, HJWL Aerts
Scientific reports 5 (1), 1-11, 2015
10512015
The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
KMA Rouschop, T van den Beucken, L Dubois, H Niessen, J Bussink, ...
The Journal of clinical investigation 120 (1), 127-141, 2010
9182010
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma
TP Coroller, P Grossmann, Y Hou, ER Velazquez, RTH Leijenaar, ...
Radiotherapy and Oncology 114 (3), 345-350, 2015
7882015
Low-dose hypersensitivity: current status and possible mechanisms
MC Joiner, B Marples, P Lambin, SC Short, I Turesson
International Journal of Radiation Oncology* Biology* Physics 49 (2), 379-389, 2001
7862001
Robust radiomics feature quantification using semiautomatic volumetric segmentation
C Parmar, E Rios Velazquez, R Leijenaar, M Jermoumi, S Carvalho, ...
PloS one 9 (7), e102107, 2014
6612014
A literature review of electronic portal imaging for radiotherapy dosimetry
W Van Elmpt, L McDermott, S Nijsten, M Wendling, P Lambin, B Mijnheer
Radiotherapy and oncology 88 (3), 289-309, 2008
6352008
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized …
V Valentini, RGPM Van Stiphout, G Lammering, MA Gambacorta, ...
Journal of clinical oncology 29 (23), 3163-3172, 2011
5722011
Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach
JA Langendijk, P Lambin, D De Ruysscher, J Widder, M Bos, M Verheij
Radiotherapy and Oncology 107 (3), 267-273, 2013
5662013
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736-745, 2015
5512015
Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer
C Parmar, RTH Leijenaar, P Grossmann, E Rios Velazquez, J Bussink, ...
Scientific reports 5 (1), 11044, 2015
4992015
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
RTH Leijenaar, G Nalbantov, S Carvalho, WJ Van Elmpt, EGC Troost, ...
Scientific reports 5 (1), 11075, 2015
4812015
Stability of FDG-PET radiomics features: an integrated analysis of test-retest and inter-observer variability
RTH Leijenaar, S Carvalho, ER Velazquez, WJC Van Elmpt, C Parmar, ...
Acta oncologica 52 (7), 1391-1397, 2013
4772013
Predicting outcomes in radiation oncology—multifactorial decision support systems
P Lambin, RGPM Van Stiphout, MHW Starmans, E Rios-Velazquez, ...
Nature reviews Clinical oncology 10 (1), 27-40, 2013
4592013
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer
D De Ruysscher, M Pijls-Johannesma, SM Bentzen, A Minken, ...
Journal of Clinical Oncology 24 (7), 1057-1063, 2006
4272006
The system can't perform the operation now. Try again later.
Articles 1–20